Michelle Stempel
Overview
Explore the profile of Michelle Stempel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
1190
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moo T, Edelweiss M, Hajiyeva S, Stempel M, Raiss M, Zabor E, et al.
Ann Surg Oncol
. 2020 Feb;
27(Suppl 3):966.
PMID: 32086652
The following are corrections to the original article.
2.
Tadros A, Moo T, Stempel M, Zabor E, Khan A, Morrow M
Breast Cancer Res Treat
. 2020 Jan;
180(1):197-205.
PMID: 31938938
Purpose: Axillary treatment strategies for the young woman with early-stage, clinically node-negative breast cancer undergoing upfront surgery found to have 1-3 positive sentinel lymph nodes (SLNs) differ significantly after BCT...
3.
Valero M, Muhsen S, Moo T, Zabor E, Stempel M, Pusic A, et al.
Ann Surg Oncol
. 2019 Dec;
27(2):344-351.
PMID: 31823173
Background: Nipple-sparing mastectomy (NSM) is increasingly performed for invasive breast cancer. Growing evidence supporting the oncologic safety of NSM has led to its widespread use and broadened indications. In this...
4.
Moo T, Jochelson M, Zabor E, Stempel M, Raiss M, Mamtani A, et al.
Ann Surg Oncol
. 2019 Oct;
26(13):4238-4243.
PMID: 31583546
Background: The National Comprehensive Cancer Network (NCCN) endorses sentinel lymph node biopsy (SLNB) in patients with clinically positive axillary nodes who downstage after neoadjuvant chemotherapy (NAC). In this study, we...
5.
Mamtani A, Zabor E, Rosenberger L, Stempel M, Gemignani M, Morrow M
Ann Surg Oncol
. 2019 Aug;
26(12):3856-3862.
PMID: 31456094
Background: The Society of Surgical Oncology and American Society for Radiation Oncology consensus guidelines defined a negative margin for breast-conserving surgery (BCS) as no ink on tumor, and implementation has...
6.
Walsh S, Brennan S, Zabor E, Rosenberger L, Stempel M, Lebron-Zapata L, et al.
Ann Surg Oncol
. 2019 Aug;
26(13):4246-4253.
PMID: 31396783
Background: Women with dense breasts may have less-accurate preoperative evaluation of extent of disease, potentially affecting the achievement of negative margins. The goal of this study is to examine the...
7.
Flanagan M, Zabor E, Romanoff A, Fuzesi S, Stempel M, Mehrara B, et al.
Ann Surg Oncol
. 2019 Jul;
26(10):3133-3140.
PMID: 31342397
Background: Many factors influence decisions regarding choice of breast-conserving surgery (BCS) versus mastectomy with reconstruction for early invasive breast cancer. The purpose of this study was to compare patient satisfaction...
8.
Mamtani A, Zabor E, Stempel M, Morrow M
Ann Surg Oncol
. 2019 Jul;
26(10):3269-3274.
PMID: 31342363
Background: The American College of Surgeons Oncology Group (ACOSOG) Z0011 trial demonstrated that axillary lymph node dissection (ALND) may be omitted for women with two or fewer positive sentinel nodes...
9.
Walsh S, Zabor E, Stempel M, Morrow M, Gemignani M
Cancer
. 2019 Jun;
125(18):3139-3146.
PMID: 31206623
Background: Black women with breast cancer have lower survival rates and higher recurrence rates in comparison with white women. This study compared treatment and survival outcomes for black and white...
10.
Flanagan M, Stempel M, Brogi E, Morrow M, Cody 3rd H
Ann Surg Oncol
. 2019 Jun;
26(9):2738-2746.
PMID: 31147995
Background: Among patients with a core biopsy diagnosis of ductal carcinoma in situ (DCIS), approximately 10% have microinvasion (DCISM), which, like DCIS, is subject to upstaging by surgical excision, but...